Matthew Perrone

Read the latest stories and analysis from Matthew Perrone.

FDA overturns safety limits on diabetes drug

FDA overturns safety limits on diabetes drug

Matthew Perrone · November 25, 2013 9:55 pm

FDA tells 23andMe to halt sales of genetic test

FDA tells 23andMe to halt sales of genetic test

Matthew Perrone · November 25, 2013 8:19 pm

Drug sales to hit lowest growth rate in decades

Drug sales to hit lowest growth rate in decades

Matthew Perrone · November 19, 2013 3:06 pm

Bulk mixers of prescribed drugs get more scrutiny

Bulk mixers of prescribed drugs get more scrutiny

Matthew Perrone · November 18, 2013 11:45 pm

Senate votes to advance specialty pharmacy bill

Senate votes to advance specialty pharmacy bill

Matthew Perrone · November 13, 2013 12:41 am

Health overhaul debate snags Senate pharmacy bill

Health overhaul debate snags Senate pharmacy bill

Matthew Perrone · November 11, 2013 10:19 pm

FDA enlists companies to head off drug shortages

FDA enlists companies to head off drug shortages

Matthew Perrone · October 31, 2013 6:16 pm

FDA approves more powerful, pure hydrocodone drug

FDA approves more powerful, pure hydrocodone drug

Matthew Perrone · October 25, 2013 9:32 pm

FDA panel backs Gilead Sciences’ hepatitis C drug

FDA panel backs Gilead Sciences’ hepatitis C drug

Matthew Perrone · October 25, 2013 8:46 pm

FDA wants limits on most prescribed painkillers

FDA wants limits on most prescribed painkillers

Matthew Perrone · October 25, 2013 12:03 am

Companies offer health benefits to transgender workers

Companies offer health benefits to transgender workers

Matthew Perrone · October 24, 2013 3:52 pm

FDA reviews 2 promising new drugs for hepatitis C

FDA reviews 2 promising new drugs for hepatitis C

Matthew Perrone · October 22, 2013 4:00 am